Western Equine Encephalitis
Western equine encephalitis (WEE) is a rare mosquito-borne alphavirus encephalitis that causes a spectrum from mild febrile illness to meningitis/encephalitis, with overall human case-fatality gene…
Western equine encephalitis (WEE) is a rare mosquito-borne alphavirus encephalitis that causes a spectrum from mild febrile illness to meningitis/encephalitis, with overall human case-fatality generally about 3%–15% and higher severity in infants and older adults; there is no proven antiviral therapy, so management is supportive, while diagnosis relies on arboviral testing of CSF and/or serum, especially virus-specific IgM/IgG, guided by geography and season.[1-4]
1. History
- Key HPI questions
- Recent mosquito exposure, outdoor activity, farming, camping, travel, or residence in endemic regions of the western/midwestern US, Canada, or parts of the Americas.[2][5-6]
- Timing of illness after exposure; reported incubation is roughly 2–7 days.[7]
- Presence of fever, headache, malaise, nausea/vomiting, then progression to confusion, somnolence, altered mental status, seizures, or focal neurologic symptoms.[1][8-9]
- Symptom characterization
- Mild flu-like syndrome vs clear CNS involvement.
- Headache severity, neck pain/stiffness, photophobia, gait change, personality change, lethargy.
- Timing, triggers, severity, progression
- Acute onset during mosquito season; worsening mental status or seizures suggests neuroinvasive disease.[2][5]
- Associated symptoms
- Fever, anorexia, depression, vomiting, meningismus, altered consciousness, seizures.[8-9]
- Important negatives
- No vesicular rash, no temporal-lobe syndrome strongly suggesting HSV, no bacterial meningitis pattern, no toxin exposure, no clear autoimmune encephalitis features.
2. Alarm Features
- Red flag symptoms/signs
- Altered mental status
- Seizures
- Focal neurologic deficits
- Severe headache with meningismus
- Coma, autonomic instability, respiratory compromise[2][8][10]
- Features suggesting life-threatening or surgical pathology
- Rapid neurologic decline, signs of raised ICP, persistent focal deficits, severe encephalopathy.
- Indications for urgent escalation
- ICU-level monitoring for airway protection, recurrent seizures, cerebral edema, or hemodynamic instability.[2]
3. Medications
- Relevant medication contributors
- No medication causes WEE specifically, but immunosuppressive drugs can broaden the encephalitis differential and complicate presentation.
- Common treatments
- Supportive care only for WEE: fluids, antipyretics, seizure management, airway/ICP support as needed.[2][4-5][11]
- In undifferentiated encephalitis, empiric acyclovir is recommended initially until HSV/VZV is reasonably excluded.[2][12]
- Contraindicated medications
- No WEE-specific contraindicated drug list established.
- Medication interactions or cautions
- Avoid anchoring on arbovirus alone if treatable etiologies remain possible; delaying HSV therapy is high risk.[2][12]
4. Diet
- Dietary triggers or recommendations
- No disease-specific dietary triggers.
- Hydration considerations
- Maintain hydration; IV fluids often required in encephalopathic patients.
- Acute vs long-term dietary management
- Acute: supportive hydration/nutrition.
- Long-term: rehabilitation phase nutrition if prolonged neurologic recovery.
5. Review of Systems
- Important ROS questions related to the diagnosis
- Fever, headache, neck stiffness, photophobia, confusion, seizure-like activity, weakness, sensory change.
- High-yield associated systems to review
- Rash/arthralgia/myalgias to help distinguish other arboviral illnesses.
- Respiratory and GI symptoms for alternative infectious causes.
- Psychiatric/behavioral change for encephalitis severity and autoimmune mimics.[5][12]
6. Collateral History and Family History
- Important collateral information
- Baseline cognition and functional status.
- Witnessed seizure, confusion, behavior change, timeline of deterioration.
- Travel and vector exposure history from family/caregivers.
- Relevant hereditary or familial conditions
- No specific hereditary predisposition established for WEE.
- Social context if clinically relevant
- Rural/agricultural exposure, housing without mosquito control, local outbreak context.
7. Risk Factors
- Major epidemiologic and clinical risk factors
- Mosquito exposure
- Endemic geography
- Infants and older adults are at higher risk of severe disease.[2][8]
- Seasonal exposure in warmer months.
- Lifestyle contributors
- Outdoor evening activity, agriculture, poor vector protection.
- Comorbidities increasing risk
- Advanced age and frailty likely worsen outcomes, though the strongest disease-specific risk signal is age group.[2][8]
8. Differential Diagnosis
- Most important alternative diagnoses
- HSV encephalitis: treat empirically pending testing.[2][12]
- West Nile neuroinvasive disease
- EEEV, St. Louis encephalitis, La Crosse encephalitis, Powassan depending on geography/season.[2-3][5]
- Enteroviral meningoencephalitis, VZV, autoimmune encephalitis.
- Dangerous cannot-miss diagnoses
- Bacterial meningitis/meningoencephalitis
- HSV encephalitis
- Brain abscess, intracranial hemorrhage, toxic-metabolic encephalopathy.
- Mimics and distinguishing features
- WEE is suggested by mosquito exposure plus seasonal neuroinvasive illness; confirmation still requires arboviral serology/PCR strategy rather than clinical pattern alone.[2-3]
9. Past Medical History
- Relevant prior conditions
- Prior seizures, neurologic disease, immunosuppression, prior arboviral infection.
- Previous episodes
- Prior encephalitis history broadens alternative diagnoses more than it supports WEE.
- Surgical history
- Neurosurgical history or shunts if CNS infection differential is broader.
- Chronic illnesses impacting management
- CKD for acyclovir dosing if empiric HSV coverage is used; cardiopulmonary disease affecting ICU risk.
10. Physical Exam
- Key exam findings
- Fever, encephalopathy, lethargy, nuchal rigidity, focal deficits, tremor or seizure activity.
- Vital sign abnormalities
- Fever; severe cases may have autonomic instability.[2]
- Focused exam maneuvers
- Full neurologic exam, mental status, cranial nerves, motor asymmetry, meningismus, skin exam for alternative vector-borne clues.
- Expected vs concerning findings
- Mild febrile illness may be nonspecific.
- Concerning: reduced consciousness, focal deficits, recurrent seizures, signs of raised ICP.
11. Lab Studies
- Recommended labs
- CBC, CMP, renal/liver function, blood cultures if febrile, inflammatory markers as adjuncts.
- Lumbar puncture when safe, with CSF cell count/diff, protein, glucose, bacterial studies, HSV/VZV PCR, and arboviral testing guided by exposure.[2-3]
- Expected abnormalities
- Viral encephalitis pattern usually shows lymphocytic pleocytosis, modestly elevated protein, and normal glucose, though early samples can be nondiagnostic.[5][13]
- Labs used to rule out dangerous conditions
- CSF bacterial profile/culture, serum metabolic evaluation, tox evaluation when indicated.
- Monitoring parameters
- Electrolytes, renal function, fluid status, seizure burden, neurologic checks.
12. Imaging
- First-line imaging
- Head CT before LP when clinically indicated to assess for contraindications to LP, mass effect, or hemorrhage.[13]
- Gold standard imaging if applicable
- Brain MRI is preferred for encephalitis evaluation generally, especially if CT is unrevealing and suspicion remains high.[12]
- Important imaging findings
- No highly specific WEE imaging signature was established in the retrieved evidence.
- When imaging is unnecessary
- Imaging may not be required before LP in low-risk patients without concern for mass effect, though many encephalitis cases still undergo neuroimaging.[12-13]
13. Special Tests
- Diagnostic scoring systems
- No WEE-specific validated bedside score identified.
- Point-of-care tests
- None specific.
- Procedures or specialty tests
- CSF and serum virus-specific IgM/IgG for arboviruses; serology is often central for diagnosis.[2-3]
- RT-PCR/NAAT may be used, but for arboviruses sensitivity can be limited outside early viremia; paired acute/convalescent serology may help.[2-3]
14. ECG
- ECG findings if applicable
- No disease-specific ECG pattern.
- Indications for ECG
- Obtain in encephalopathic/critically ill patients, especially if arrhythmia, electrolyte disturbance, or autonomic instability is suspected.[2]
- Dangerous ECG patterns to recognize
- Arrhythmias related to critical illness rather than WEE-specific electrophysiology.
15. Assessment
- Clinical summary
- WEE is an uncommon but potentially severe arboviral encephalitis. Most concern arises when a patient has seasonal mosquito exposure plus fever and evolving CNS symptoms.[1-2][5]
- Severity stratification
- Mild febrile illness without CNS findings vs neuroinvasive disease with meningitis/encephalitis.
- Highest concern in infants and older adults.[2][8]
- Typical vs atypical presentations
- Typical: febrile illness progressing to encephalitis/meningitis.
- Atypical: isolated mild illness, or nonspecific altered mental status without clear meningeal signs.
- Complications to consider
- Seizures, cerebral edema, prolonged encephalopathy, cognitive/sensory/motor deficits, emotional instability, and chronic neurologic sequelae in survivors.[10][14-15]
16. Treatment Plan
- Initial stabilization
- ABCs, airway protection if encephalopathic, seizure precautions, neuro checks, antipyresis, IV fluids.[2]
- Medications and dosing when appropriate
- No approved antiviral treatment for WEE.[4-5][11]
- In undifferentiated encephalitis, start empiric IV acyclovir while evaluating for HSV/VZV, adjusting for renal function.[2][12]
- Standard antiseizure therapy for seizures/status epilepticus as clinically indicated.
- Outpatient vs inpatient treatment
- Suspected WEE with CNS involvement generally warrants hospital admission; ICU if severe encephalitis.[2]
- Procedures/interventions
- LP when safe, MRI/EEG as indicated, airway/ICP management for severe cases.
- Follow-up management
- Rehabilitation, neurology follow-up, cognitive/functional reassessment for sequelae.[10][14]
17. Disposition
- Admission criteria
- Any encephalitis/meningitis features, altered mental status, seizures, inability to maintain hydration, diagnostic uncertainty requiring LP/monitoring.
- Discharge criteria
- Only reasonable if there is no CNS involvement, low suspicion for encephalitis, stable exam, and an alternative benign diagnosis is established.
- Observation indications
- Evolving symptoms without clear CNS findings but concern for early neuroinvasive disease.
- Specialist consultation triggers
- Infectious diseases, neurology, ICU, and public health/laboratory coordination for arboviral testing.
18. Follow Up / Return Precautions
- Follow-up timing
- Inpatient neurology/ID follow-up during admission; after discharge, close follow-up for neurocognitive and functional recovery.
- Symptoms requiring immediate reassessment
- Confusion, seizure, worsening headache, vomiting, focal weakness, gait change, somnolence, or persistent fever.
- Patient counseling points
- No established human vaccine or outpatient antiviral treatment; prevention relies on mosquito avoidance and vector control.[1][4]
- Expected recovery course
- Recovery can be prolonged; some survivors have persistent neurologic deficits, especially after severe encephalitic disease.[10][14]
References
1. Safety and Immunogenicity of a Trivalent Virus-Like Particle Vaccine Against Western, Eastern, and Venezuelan Equine Encephalitis Viruses: A Phase 1, Open-Label, Dose-Escalation, Randomised Clinical Trial. — Coates EE, Edupuganti S, Chen GL, et al. The Lancet. Infectious Diseases. 2022.
2. Acute Viral Encephalitis. — Tyler KL. The New England Journal of Medicine. 2018.
3. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
4. Western Equine Encephalitis Virus: A Comprehensive Review of Epidemics, Transmission, Hosts, and Strategies for Mitigation. — Wang L, Zheng R, Li Z, Zhang L. Virulence. 2025.
5. Acute Encephalitis in Immunocompetent Adults. — Venkatesan A, Michael BD, Probasco JC, Geocadin RG, Solomon T. Lancet. 2019.
6. Encephalitic Alphaviruses. — Zacks MA, Paessler S. Veterinary Microbiology. 2010.
7. Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti‐Alphavirus Therapies. — Wang S, Mahalingam S, Merits A. Reviews in Medical Virology. 2025.
8. Viral Encephalitis: Familiar Infections and Emerging Pathogens. — Whitley RJ, Gnann JW. Lancet. 2002.
9. Alphaviral Equine Encephalomyelitis (Eastern, Western and Venezuelan). — Aréchiga-Ceballos N, Aguilar-Setién A. Revue Scientifique Et Technique. 2015.
10. Neurological Sequelae Resulting From Encephalitic Alphavirus Infection. — Ronca SE, Dineley KT, Paessler S. Frontiers in Microbiology. 2016.
11. Treatment of Viral Encephalitis. — Aksamit AJ. Neurologic Clinics. 2021.
12. State of the Art: Acute Encephalitis. — Bloch KC, Glaser C, Gaston D, Venkatesan A. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2023.
13. Encephalitis. — Binks SNM, Saylor D, Easton A, Thakur KT, Irani SR. Lancet. 2026.
14. Sequelae and Animal Modeling of Encephalitic Alphavirus Infections. — Reyna RA, Weaver SC. Viruses. 2023.
15. The Causes and Long-Term Consequences of Viral Encephalitis. — Bohmwald K, Andrade CA, Gálvez NMS, et al. Frontiers in Cellular Neuroscience. 2021.